It has also been reported that FKBP12 bound to RapaLink-1 enhances the accumulation of Rapalink-1 molecules inside the cell, and thus makes it a potential drug to inhibit cancer-associated activating mTOR mutant [134,135]. This evidence concerns the gene MTOR and cancer.